ArticleHuman vaccines & immunotherapeutics2025
Vaccination coverage, willingness and determinants of herpes zoster vaccine among individuals aged 50 and above in Ningbo, China: A population-based cross-sectional study.
Article in Human vaccines & immunotherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Herpes zoster as a vaccine-preventable risk factor increases the risk of dementia: A nested case-control study in Chinese population.Human vaccines & immunotherapeutics · 2026Article
- The emerging link between shingles vaccination and reduced Alzheimer's risk: a public health signal for viral-dementia pathways.Annals of medicine and surgery (2012) · 2026Article
- Mitigating Vaccine Disparities Through Faith-Based Intervention: A Pre-Post Analysis of Recombinant Zoster Vaccine Knowledge and Acceptance in Socially Vulnerable Racial and Ethnic Minoritized Communities.Infectious diseases and therapy · 2026Article
- Real-World Vaccination Data Analysis for Three Vaccines Among Individuals Aged 60 and Older in Shanghai, China.Vaccines · 2026Article
- Rising Burden of Herpes Zoster among General Adults and Increased-Risk Groups in Eastern China, 2015-2021: A Population-Based Cohort Study.Infectious diseases and therapy · 2026Article
- The related factors for influencing herpes zoster vaccination and willingness among older adults aged ≥60 years in China: A conditional inference tree analysis and traditional logistic regression.Human vaccines & immunotherapeutics · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Insufficient coverage of herpes zoster vaccination is a challenge faced by China. This study explores herpes zoster vaccination coverage, willingness, and their predictive factors among individuals aged 50 and above in Ningbo City, aiming to formulate evidence-based health education intervention strategies.From March to June 2024, a questionnaire survey was conducted using a multi-stage sampling method on permanent residents aged 50 years and above in Ningbo City. Rao-Scott chi-square test and logistic regression analyzed predictors of herpes zoster vaccination coverage and willingness. Findings revealed a 1.21% vaccination rate, with 36.05% willing but unvaccinated. Among those not vaccinated, key barriers included lack of awareness (48.20%), perceived low risk (28.22%), and cost concerns (15.90%). Logistic regression identified lower coverage among non-civil servants and higher coverage among those with coresidence with adult children, monthly income ≥US$685USD, near-good self-rated health, herpes zoster knowledge score ≥14, and medical staff recommendations. Lower willingness was seen in those aged 60 and above (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.